Losartan in Treating Pulmonary Fibrosis in Patients With Stage I, II, or III Non-Small Cell Lung Cancer
Status:
Withdrawn
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Losartan potassium may be effective in treating pulmonary fibrosis caused by
radiation therapy in patients with non-small cell lung cancer.
PURPOSE: This clinical trial is studying losartan to see how well it works in treating
pulmonary fibrosis caused by radiation therapy in patients with stage I, stage II, or stage
III non-small cell lung cancer.